Is a complete ACTU research report available?

No complete published report is available for Actuate Therapeutics, Inc. (ACTU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Actuate Therapeutics, Inc. (ACTU)

NASDAQ: ACTU · USD

$0.40

+0.00 (+0.1%)· Recorded snapshot

Market cap	9.6M
Net income (ttm)	-20.5M
EPS (ttm)	-$0.89
Shares out	24M
Volume	486,519
Beta	1.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -20.5M
EPS (ttm): -$0.89
Market cap: 9.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001652935
Company name	Actuate Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	005083100
Earnings date	2026-11-12
Earnings time	amc
Employees	12
Employees change	2
Employees growth	20%
Enterprise value	$5.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Biotechnology
IPO date	2024-08-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US0050831009
Last 10-K release date	2026-03-26
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$9.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$0.40
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ACTU
U.S. state	Texas
Website	https://actuatetherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001652935

Company name

Actuate Therapeutics, Inc.

Country

United States

Country code

CUSIP number

005083100

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

Employees growth

20%

Enterprise value

$5.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

Industry

Biotechnology

IPO date

2024-08-13

Is primary listing

Yes

Is SPAC

ISIN number

US0050831009

Last 10-K release date

2026-03-26

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$9.6M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$0.40

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ACTU

U.S. state

Texas

Website

https://actuatetherapeutics.com

Metric	Value
Earnings yield	-221.64%
FCF / EV yield	-457.12%
FCF yield	-226.31%
P/B ratio	9.7x
Price / tangible book value	8.86x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-221.64%

FCF / EV yield

-457.12%

FCF yield

-226.31%

P/B ratio

9.7x

Price / tangible book value

8.86x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-1.7M
ROA	-213.4%
ROCE	-1,490.05%

Metric

Value

Profit per employee

$-1.7M

ROA

-213.4%

ROCE

-1,490.05%

Metric	Value
EPS growth quarters	2
EPS growth years	2
Net income growth quarters	8
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
EBIT	$-20.8M
EPS	$-0.89
FCF per share	$-0.83
Financing cash flow	$17.8M
Free cash flow	$-19.8M
Free cash flow minus SBC	$-25.9M
Net cash flow	$-2.1M
Net income	$-20.5M
Operating cash flow minus SBC	$-25.9M
Operating income	$-20.8M
Stock-based compensation	$6M

Metric

Value

EBIT

$-20.8M

EPS

$-0.89

FCF per share

$-0.83

Financing cash flow

$17.8M

Free cash flow

$-19.8M

Free cash flow minus SBC

$-25.9M

Net cash flow

$-2.1M

Net income

$-20.5M

Operating cash flow minus SBC

$-25.9M

Operating income

$-20.8M

Stock-based compensation

$6M

Metric	Value
Book value per share	$0.04
Debt / equity	0
Interest coverage	-1,025.85
Long-term assets	$451,398
Long-term liabilities	$404,991
Net cash (debt)	$4.4M
Net cash / market cap	50.49%
Net cash growth	-31.83%
Net debt / equity	-4.47
Piotroski F-Score	2
Shareholders' equity	$989,152
Tangible book value	$989,152
Tangible book value per share	$0.04
Total assets	$5.2M
Total cash	$4.4M
Total debt	$0
Total liabilities	$4.2M
WACC	10.85%

Metric

Value

Book value per share

$0.04

Debt / equity

Interest coverage

-1,025.85

Long-term assets

$451,398

Long-term liabilities

$404,991

Net cash (debt)

$4.4M

Net cash / market cap

50.49%

Net cash growth

-31.83%

Net debt / equity

-4.47

Piotroski F-Score

Shareholders' equity

$989,152

Tangible book value

$989,152

Tangible book value per share

$0.04

Total assets

$5.2M

Total cash

$4.4M

Total debt

Total liabilities

$4.2M

WACC

10.85%

Metric	Value
Current assets	$4.7M
Current liabilities	$3.8M
Current ratio	1.25
Net working capital	$-3.5M
Quick ratio	1.16
Working capital	$942,745

Metric

Value

Current assets

$4.7M

Current liabilities

$3.8M

Current ratio

1.25

Net working capital

$-3.5M

Quick ratio

1.16

Working capital

$942,745

Metric	Value
Buyback yield / dilution	-32.82%
Dividend yield	0%
Shareholder yield	-32.82%

Metric

Value

Buyback yield / dilution

-32.82%

Dividend yield

Shareholder yield

-32.82%

Metric	Value
150-day SMA	$1.61
1D price change	0.05%
1M price change	-41.22%
1M total return	-41.22%
1W price change	-28.9%
1W total return	-28.9%
1Y price change	-94.5%
1Y return CAGR	-94.51%
1Y total return	-94.5%
20-day SMA	$0.61
200-day SMA	$2.21
3M price change	-65.24%
3M total return	-65.24%
50-day SMA	$0.93
50-day SMA vs 200-day SMA	50under200
52-week high	$7.90
52-week high date	2025-12-10
52-week low	$0.35
52-week low date	2026-10-27
6M price change	-85.98%
6M total return	-85.98%
All-time high	$11.99
All-time high date	2025-05-30
All-time low	$0.35
All-time low date	2026-10-27
Average true range (ATR)	$0.13
Average volume	494.9K
Beta (1Y)	1.75
Beta (2Y)	1.42
Beta (5Y)	1.2
Change from 52-week high	-94.94%
Change from 52-week low	14.2%
Change from all-time high	-96.67%
Change from all-time low	14.2%
Change from open	3.02%
Day's gap	-2.88%
Dollar volume	$194,462
High price	$0.40
Low price	$0.36
Monthly RSI	32.88
Open price	$0.39
Position in 52-week range	100%
Premarket change	2.58%
Premarket close	$0.40
Premarket price	$0.41
Premarket volume	3.2K
Previous close	$0.40
Price vs 150-day SMA	-75.24%
Price vs 20-day SMA	-34.23%
Price vs 200-day SMA	-81.91%
Price vs 50-day SMA	-57.16%
Relative volume	1.01
Return from IPO open	-96.31%
Return from IPO price	-95.44%
RSI	33.99
Sharpe ratio	-1.9
Sortino ratio	-2.57
Volume	486.5K
Weekly RSI	29.21
YTD price change	-93.47%
YTD total return	-93.47%

Metric

Value

150-day SMA

$1.61

1D price change

0.05%

1M price change

-41.22%

1M total return

-41.22%

1W price change

-28.9%

1W total return

-28.9%

1Y price change

-94.5%

1Y return CAGR

-94.51%

1Y total return

-94.5%

20-day SMA

$0.61

200-day SMA

$2.21

3M price change

-65.24%

3M total return

-65.24%

50-day SMA

$0.93

50-day SMA vs 200-day SMA

50under200

52-week high

$7.90

52-week high date

2025-12-10

52-week low

$0.35

52-week low date

2026-10-27

6M price change

-85.98%

6M total return

-85.98%

All-time high

$11.99

All-time high date

2025-05-30

All-time low

$0.35

All-time low date

2026-10-27

Average true range (ATR)

$0.13

Average volume

494.9K

Beta (1Y)

1.75

Beta (2Y)

1.42

Beta (5Y)

1.2

Change from 52-week high

-94.94%

Change from 52-week low

14.2%

Change from all-time high

-96.67%

Change from all-time low

14.2%

Change from open

3.02%

Day's gap

-2.88%

Dollar volume

$194,462

High price

$0.40

Low price

$0.36

Monthly RSI

32.88

Open price

$0.39

Position in 52-week range

100%

Premarket change

2.58%

Premarket close

$0.40

Premarket price

$0.41

Premarket volume

3.2K

Previous close

$0.40

Price vs 150-day SMA

-75.24%

Price vs 20-day SMA

-34.23%

Price vs 200-day SMA

-81.91%

Price vs 50-day SMA

-57.16%

Relative volume

1.01

Return from IPO open

-96.31%

Return from IPO price

-95.44%

RSI

33.99

Sharpe ratio

-1.9

Sortino ratio

-2.57

Volume

486.5K

Weekly RSI

29.21

YTD price change

-93.47%

YTD total return

-93.47%

Metric	Value
Float	8.6M
Float percentage	35.83%
Shares change (QoQ)	1.42%
Shares change (YoY)	32.82%
Shares held by insiders	5.33%
Shares held by institutions	6.77%
Shares outstanding	24M
Short % of float	15.46%
Short % of shares	5.54%
Short ratio	4.6 days

Metric

Value

Float

8.6M

Float percentage

35.83%

Shares change (QoQ)

1.42%

Shares change (YoY)

32.82%

Shares held by insiders

5.33%

Shares held by institutions

6.77%

Shares outstanding

24M

Short % of float

15.46%

Short % of shares

5.54%

Short ratio

4.6 days

Actuate Therapeutics, Inc. (ACTU)

Price

Financial snapshot

Fair-value bridge

Latest news · ACTU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACTU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ACTU

Frequently asked questions